UNLOXCYT
NDC 70095-130, cosibelimab, injection, solution, from Sun Pharmaceutical Industries, Inc..
- Product NDC
- 70095-130
- Status
- Listed
- Labeler
- Sun Pharmaceutical Industries, Inc.
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761297
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70095-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- COSIBELIMAB300 mg/5mL
Pharmacologic classes
Antibodies, Monoclonal [CS]; Programmed Death Ligand-1 Antagonists [MoA]; Programmed Death Ligand-1 Blocker [EPC]; Programmed Death Ligand-1-directed Antibody Interactions [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70095-130-01 | 70095013001 | 1 VIAL, GLASS in 1 CARTON (70095-130-01) / 5 mL in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/06bdadd5-d2db-406f-a3f8-de47f48a52e3Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=70095-130
Use it
Look up 70095-130 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70095-130 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70095-130. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.